← Leaderboards
Garrett M Fitzmaurice
Harvard University (Sch Of Public Hlth)
$4,095,301
Attributed
$4,095,301
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $448.9K · FY2005–21$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$4,095,301 · 4
By mechanism
T32$1,323,914 · 1
R33$1,306,868 · 1
R01$988,842 · 1
R21$475,677 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Sch Of Public Hlth)
Same institution · by research overlap
- Karestan C Koenen$26,970,090
- Walter C. Willett$98,918,122
- Jay G Silverman$6,401,819
- Kenneth Hill$902,400
- Nan McKenzie Laird$5,541,809
Others in their field
Top investigators on “Longitudinal Analysis”
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- David R. Weir · University Of Michigan At Ann Arbor$101,829,547
- James D Crapo · University Of Colorado Denver$97,835,516
- Paul S. Aisen · Cognition Therapeutics, Inc.$93,653,614
- Constance Ann Benson · University Of California, San Diego$82,165,953
- Lisa P Jacobson · Johns Hopkins University$78,534,458
Research focus
Longitudinal AnalysisMeasurementFrequenciesLegalFunctional OutcomesClinical TrialsCocaine UseBaseAbstinenceFutureAftercareFlexibilityData SetDesignDocumentationDropoutCommunitiesDrug UsageClinically RelevantEmploymentComputer SoftwareFollow-UpFamilyMedical
Grant awards (15)
Reduction in frequency of drug use as a primary outcome and its relation to changes in health-related and other functional outcomes in stimulant use disorder trials$428,991
R33 · FY2021 · DA · contact PI
Reduction in frequency of drug use as a primary outcome and its relation to changes in health-related and other functional outcomes in stimulant use disorder trials$428,991
R33 · FY2020 · DA · contact PI
Reduction in frequency of drug use as a primary outcome and its relation to changes in health-related and other functional outcomes in stimulant use disorder trials$448,886
R33 · FY2019 · DA · contact PI
Reduction in frequency of drug use as a primary outcome and its relation to changes in health-related and other functional outcomes in stimulant use disorder trials$230,884
R21 · FY2017 · DA · contact PI
Reduction in frequency of drug use as a primary outcome and its relation to changes in health-related and other functional outcomes in stimulant use disorder trials$244,793
R21 · FY2016 · DA · contact PI
Training Program in Psychiatric Genetics and Translational Research$290,138
T32 · FY2013 · MH · contact PI
Training Program in Psychiatric Genetics and Translational Research$346,059
T32 · FY2012 · MH · contact PI
Training Program in Psychiatric Genetics and Translational Research$342,320
T32 · FY2011 · MH · contact PI
Training Program in Psychiatric Genetics and Translational Research$345,397
T32 · FY2010 · MH · contact PI
Methods for the Analysis of Longitudinal Data$211,644
R01 · FY2005 · GM
Methods for the Analysis of Longitudinal Data$110,296
R01 · FY2004 · GM
Methods for the Analysis of Longitudinal Data$98,751
R01 · FY2004 · GM
Methods for the Analysis of Longitudinal Data$244,626
R01 · FY2003 · GM
METHODS FOR ANALYSIS OF LONGITUDINAL AND FAMILIAL DATA$163,192
R01 · FY2002 · GM
METHODS FOR ANALYSIS OF LONGITUDINAL AND FAMILIAL DATA$160,333
R01 · FY2001 · GM